Treatment of CNVM secondary to idiopathic juxtafoveal retinal telangiectasis by transpupillary thermotherapy.

作者信息

Nachiappan Kasinathan, Shanmugam Mahesh P

出版信息

Am J Ophthalmol. 2005 Mar;139(3):577-8; author reply 578. doi: 10.1016/j.ajo.2004.10.014.

DOI:10.1016/j.ajo.2004.10.014

PMID:15767092

Abstract

摘要

相似文献

Treatment of CNVM secondary to idiopathic juxtafoveal retinal telangiectasis by transpupillary thermotherapy.

Am J Ophthalmol. 2005 Mar;139(3):577-8; author reply 578. doi: 10.1016/j.ajo.2004.10.014.

Transpupillary thermotherapy for subfoveal neovascularization secondary to group 2A idiopathic juxtafoveolar telangiectasis.

Am J Ophthalmol. 2004 Jul;138(1):147-9. doi: 10.1016/j.ajo.2004.01.047.

Chorioretinal anastomosis probably occurs infrequently in type 2A idiopathic juxtafoveolar retinal telangiectasis.

Arch Ophthalmol. 2003 Sep;121(9):1345-6. doi: 10.1001/archopht.121.9.1345-b.

[Type IIA juxtafoveal telangiectasis associated with subretinal neovascularisation].

Oftalmologia. 2009;53(3):113-7.

Re: Optical coherence tomography findings in nonproliferative group 2a idiopathic juxtafoveal retinal telangiectasis.

Retina. 2008 Feb;28(2):368-9; author reply 369-70. doi: 10.1097/IAE.0b013e31815ec3e3.

Idiopathic juxtafoveal telangiectasis in association with celiac sprue.

Arch Ophthalmol. 2004 Mar;122(3):411-3. doi: 10.1001/archopht.122.3.411.

Bilateral subretinal neovascular membrane in idiopathic juxtafoveolar telangiectasis.

Retina. 1996;16(4):344-6. doi: 10.1097/00006982-199616040-00014.

Intravitreal ranibizumab and bevacizumab for bilateral subretinal neovascularization secondary to idiopathic juxtafoveal telangiectasia type 2A.

Acta Ophthalmol. 2009 Nov;87(8):930-2. doi: 10.1111/j.1755-3768.2009.01598.x.

Idiopathic juxtafoveolar retinal telangiectasis: case report and literature review.

Optometry. 2002 Feb;73(2):103-12.

[Idiopathic juxtafoveolar retinal telangiectasis in the adult].

Bull Soc Ophtalmol Fr. 1984 May;84(5):609-12.

引用本文的文献

A complete clinical review of idiopathic macular telangiectasia.

Oman J Ophthalmol. 2023 May 26;16(3):421-426. doi: 10.4103/ojo.ojo_170_22. eCollection 2023 Sep-Dec.

Long-Term Outcomes in Macular Telangiectasia Type 2 With Subretinal Neovascularization.

J Vitreoretin Dis. 2020 Jun 17;4(5):386-392. doi: 10.1177/2474126420927149. eCollection 2020 Sep-Oct.

Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization.

Turk J Ophthalmol. 2022 Feb 23;52(1):45-49. doi: 10.4274/tjo.galenos.2021.75608.

Idiopathic juxtafoveolar retinal telangiectasis: a current review.

Middle East Afr J Ophthalmol. 2010 Jul;17(3):224-41. doi: 10.4103/0974-9233.65501.

One-year results of verteporfin therapy for subretinal neovascularization associated with type 2A parafoveal telengiectasia.

Clin Ophthalmol. 2007 Dec;1(4):483-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验